Improving weight loss outcomes by treating insomnia in breast cancer survivors
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
This study is looking at how improving sleep through therapy can help women who have survived breast cancer lose weight more effectively, making it easier for them to stay healthy and reduce the chance of cancer coming back.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10867335 on NIH RePORTER |
What this research studies
This research investigates how treating insomnia can enhance weight loss efforts in women who have survived breast cancer. It focuses on using cognitive-behavioral therapy for insomnia (CBT-I) to improve sleep quality before starting a behavioral weight loss program. By addressing sleep issues, the study aims to help participants achieve more significant and sustained weight loss, which is crucial for reducing the risk of breast cancer recurrence and improving overall health. The approach combines behavioral interventions with a focus on sleep to tackle the challenges faced by breast cancer survivors in managing their weight.
Who could benefit from this research
Good fit: Ideal candidates for this research are adult women who are breast cancer survivors and are experiencing insomnia and overweight or obesity.
Not a fit: Patients who are not breast cancer survivors or those who do not have insomnia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective weight loss strategies for breast cancer survivors, improving their health outcomes and quality of life.
How similar studies have performed: Previous studies have shown that cognitive-behavioral therapy for insomnia is effective in breast cancer survivors, but this specific approach of combining it with weight loss interventions is novel.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Wilder Coughlin, Janelle — Johns Hopkins University
- Study coordinator: Wilder Coughlin, Janelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.